Home
G-15

G-15

Catalog No.

B5469

GPER receptor antagonist

Skip to the beginning of the images gallery

Grouped product items
Size	Price	Stock	Qty
10mg	$140.00	In stock

For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background
Product Citation
Chemical Properties
Protocol
Quality Control

Background

G-15 (CAS 1161002-05-6) is a selective antagonist of G protein-coupled receptor 30 (GPR30), with a Ki of approximately 20 nM. GPR30 is an integral membrane receptor residing in the endoplasmic reticulum, mediating intracellular signaling responses triggered by ligands such as estradiol. G-15 specifically inhibits GPR30-mediated pathways without significantly interacting with estrogen receptors ERα or ERβ, even at higher concentrations. In cellular studies, G-15 blocks estrogen- or G-1-induced elevations of intracellular calcium and PI3K activation. In vivo research demonstrates that G-15 disrupts estradiol-associated improvements in spatial learning tasks, emphasizing its utility in investigating GPR30 function and estrogen signaling mechanisms.

Product Citation

Hide ↑↑

Chemical Properties

Physical Appearance	A solid
Storage	Store at -20°C
M.Wt	370.24
Cas No.	1161002-05-6
Formula	C₁₉H₁₆BrNO₂
Solubility	insoluble in H2O; insoluble in EtOH; ≥37 mg/mL in DMSO
Chemical Name	(3aR,4S,9bS)-4-(6-bromobenzo[d][1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline
SDF	Download SDF
Canonical SMILES	BrC1=C([C@H]2NC3=CC=CC=C3[C@]4([H])[C@@]2([H])CC=C4)C=C5OCOC5=C1
Shipping Condition	Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips	We do not recommend long-term storage for the solution, please use it up soon.

Protocol

Cell experiment [1,2]:
Cell lines	Immortalized epithelial endometriotic cell line (11z)
Preparation method	The solubility of this compound in DMSO is >10 mM. General tips for obtaining a higher concentration: Please warm the tube at 37°C for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20°C for several months.
Reacting condition	10, 30, or 60 μM for 24, 48, or 72 hours
Applications	G-1 (30 μM) led to Akt phosphorylation at serine 473 within 2 hours. Pretreatment with G-15 (60 μM) prevented this phosphorylation by G-1. Treatment with 10 μM G-1 for 72 hours significantly stimulated the cells with an increase of the relative proliferation. A subsequent 72-hour treatment with 30 μM G-15 significantly reversed this stimulation. Treatment with G-15 alone led to a decrease of the relative proliferation. G-15 dose-dependently inhibited G-1-mediated calcium mobilization in SKBr3 cells with IC50 of ~185 nM. G15 inhibited the G-1-mediated activation of PI (3) K in GPR30-transfected COS7 cells.
Animal experiment [3]:
Animal models	Ovariectomized female rats
Dosage form	Subcutaneous injection, 5 μg/day, 10 μg/day
Application	G-15 dose-dependently impaired DMP acquisition. G-15 specifically reduced the rate of acquisition.
Other notes	Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.
References: [1] Imesch P, Samartzis E P, Dedes K J, et al. Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells [J]. Fertility and sterility, 2013, 100 (3): 770-776. [2] Dennis M K, Burai R, Ramesh C, et al. In vivo effects of a GPR30 antagonist [J]. Nature chemical biology, 2009, 5 (6): 421-427. [3] Hammond R, Nelson D, Kline E, et al. Chronic treatment with a GPR30 antagonist impairs acquisition of a spatial learning task in young female rats [J]. Hormones and behavior, 2012, 62 (4): 367-374.